Bilateral injections of AAV vectors encoding for stimulatory (AAV8-hSyn-DIO-hM3Dq-mCherry, Addgene, 44361-AAV8) or inhibitory (AAV8-hSyn-dF-HA-KORD-IRES-mCitrine, Addgene, 65417-AAV8) Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) were then performed in the OB (A/P: +4.8 mm from bregma, M/L: 1 mm and D/V: 1.7 mm from brain surface) at a rate of 0.125 L/min for 4 min, on Glp1r -Cre RD and WD mice
Abstract Tirzepatide (TRZ) is a dual agonist of glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors that were recently approved for the treatment of type 2 diabetes (T2D) and obesity
Proper peptide storage and handling prove essential, with lyophilized peptides requiring storage at -20C or lower (optimally -80C) away from bright light and moisture, and peptides containing cysteine, methionine, or tryptophan requiring additional protection from oxidation through anaerobic storage conditions to maintain stability and biological activity throughout experimental protocols
Primer sequences are listed in Supplementary Information 1
10.1042/bj0600604 Biochem
Anam M, Maharjan S, Amjad Z, Abaza A, Vasavada AM, Sadhu A, Valencia C, Fatima H, Nwankwo I (2022) Efficacy of semaglutide in treating obesity: a systematic review of randomized controlled trials (RCTs)
